118 related articles for article (PubMed ID: 10573824)
1. [Effect of long-term hormone substitution therapy on serum TSH level in postmenopausal women].
Foth D; Römer T
Zentralbl Gynakol; 1999; 121(10):495-8. PubMed ID: 10573824
[TBL] [Abstract][Full Text] [Related]
2. Thyroid function and postmenopause.
Schindler AE
Gynecol Endocrinol; 2003 Feb; 17(1):79-85. PubMed ID: 12724022
[TBL] [Abstract][Full Text] [Related]
3. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
Maffei S; Del Ry S; Prontera C; Clerico A
Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
[TBL] [Abstract][Full Text] [Related]
4. Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results.
Erel CT; Gezer A; Sentürk LM; Somunkiran A; Kaleli S; Seyisoglu H
J Reprod Med; 2007 Dec; 52(12):1079-84. PubMed ID: 18210897
[TBL] [Abstract][Full Text] [Related]
5. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.
Park HT; Cho GJ; Ahn KH; Shin JH; Hong SC; Kim T; Hur JY; Kim YT; Lee KW; Kim SH
Maturitas; 2009 Mar; 62(3):301-5. PubMed ID: 19250778
[TBL] [Abstract][Full Text] [Related]
6. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
Im JA; Lee JW; Lee HR; Lee DC
Maturitas; 2006 Apr; 54(1):65-71. PubMed ID: 16198517
[TBL] [Abstract][Full Text] [Related]
7. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of thyroid disease in an older Australian population.
Empson M; Flood V; Ma G; Eastman CJ; Mitchell P
Intern Med J; 2007 Jul; 37(7):448-55. PubMed ID: 17547723
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant effect of cavinton in the treatment of climacteric symptoms.
Kiss E
Ther Hung; 1990; 38(4):170-3. PubMed ID: 2094056
[TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
Grisar J; Travica S; Metka M; Pietschmann P
Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
[TBL] [Abstract][Full Text] [Related]
11. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
Giavoli C; Porretti S; Ferrante E; Cappiello V; Ronchi CL; Travaglini P; Epaminonda P; Arosio M; Beck-Peccoz P
Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926
[TBL] [Abstract][Full Text] [Related]
12. High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women.
Lambrinoudaki I; Armeni E; Rizos D; Georgiopoulos G; Kazani M; Alexandrou A; Deligeoroglou E; Livada A; Psychas C; Creatsa M; Bouboulis G; Alevizaki M; Stamatelopoulos K
J Hypertens; 2012 Mar; 30(3):592-9. PubMed ID: 22227818
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
Thorp JM; Gavin NI; Ohsfeldt RL
Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal changes in serum cytokine levels and hormone replacement therapy.
Kamada M; Irahara M; Maegawa M; Ohmoto Y; Takeji T; Yasui T; Aono T
Am J Obstet Gynecol; 2001 Feb; 184(3):309-14. PubMed ID: 11228479
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
Zofkova I; Hill M
Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
[TBL] [Abstract][Full Text] [Related]
17. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone.
Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA
J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119
[TBL] [Abstract][Full Text] [Related]
18. Interaction of estrogen therapy and thyroid hormone replacement in postmenopausal women.
Mazer NA
Thyroid; 2004; 14 Suppl 1():S27-34. PubMed ID: 15142374
[TBL] [Abstract][Full Text] [Related]
19. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
20. Estimation of hormone replacement therapy influence on serum galanin level in postmenopausal women.
Meczekalski B; Słopień R; Warenik-Szymankiewicz A
Climacteric; 2001 Sep; 4(3):215-8. PubMed ID: 11588945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
